Former FDA counsel Pollard joins law firm
This article was originally published in The Silver Sheet
Executive Summary
Former FDA Associate Chief Counsel Vernessa Pollard has joined the Washington, D.C., office of law firm Arnold & Porter, where she will focus on FDA and health care practice issues. During her tenure at the agency from 2002 to 2008, Pollard represented FDA in a variety of litigation matters, including a recent enforcement action that resulted in a consent decree against a device firm. She also handled the agency's first administrative action seeking civil money penalties from a manufacturer for violating Medical Device Reporting (MDR) requirements
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.